Asieris
1 known investors
Find your way into Asieris
Sign up to see every warm intro you have to Asieris
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asieris team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Asieris Pharmaceuticals develops and commercializes drugs and diagnostic devices focused on cancer and other therapeutic areas, including treatments for advanced solid tumors and urological conditions. Its pipeline spans small-molecule drugs, antibody-drug conjugates, and imaging devices such as cystoscopes.
Investors · 1
Frequently asked questions
- What does Asieris do?
- Asieris Pharmaceuticals develops and commercializes drugs and diagnostic devices focused on cancer and other therapeutic areas, including treatments for advanced solid tumors and urological conditions. Its pipeline spans small-molecule drugs, antibody-drug conjugates, and imaging devices such as cystoscopes.
- Who are Asieris's investors?
- Asieris's investors include BioTrack Capital.